Powder-in-capsule (Micro-dosing) Equipment
Micro-dosing is the process of dispensing a precise amount of drug substance into a capsule (or other container, e.g. vial or bottle), for use in early phase human studies (phase I safety evaluations).
Preformulation & Preclinical Services
Drug substance “powder-in-capsule” (PIC) studies generally avoid the use of excipients – and the compatibility and stability studies associated with their use – for these initial evaluations thereby accelerating early phase product development timelines. Accelerating these initial studies to determine if the drug substance should receive further investment is critical in cost-effective product development.
A summary of PIC program benefits using Xcelodose® Micro-dosing Systems follows:
- Streamlines product development
- Minimizes drug substance usage in formulation development
- Eliminates excipient compatibility screening
- Simplifies analytical and stability evaluations
- Increases efficiencies via programmable and precise dispensing of drug substance into capsules
- Provides supporting documentation including weights for each capsule produced
- Cost effective
- Reduces waste of material
- Minimizes analytical and formulation development costs
- Allows for multiple strengths to be prepared for the clinic using the same process
Centers of Excellence
Lonza offers PIC services using Xcelodose Systems in North America (Xcelience – Tampa, FL) and Europe (Ploermel, FR). Both sites have integrated product development and manufacturing, and multiple Xcelodose® units to support both pre-clinical assessments and clinical PIC manufacture. A full range of preformulation, analytical and formulation development services support phase I-IV studies and commercialization.
Select the Micro-dosing System that meets your needs
- Xcelolab® for lab-scale
- Xcelodose® 120S: semi-automated
- Xcelodose® 600S: fully automated